2021 annual financial data
MoonLake Immunotherapeutics 2021 Operating cash flow
Direct answer
Operating cash flow was -35,175,194 USD.
Operating income was -4,570,345 USD and net income was -4,542,654 USD.
Operating cash flow was -35,175,194 USD.
Get free MoonLake Immunotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -4,570,345 USD
- Net income
- -4,542,654 USD
- Operating cash flow
- -35,175,194 USD